Kimia Biosciences P/B Ratio
Kimia Biosciences (KIMIABL) P/B ratio is 15.06 (High), book value per share ₹20.00 vs Healthcare average P/B of -0.94 — Very High - Significant premium, high growth expectations or speculative. Compare with Kimia Biosciences value estimation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
KIMIABL P/B Ratio — Valuation Insights & Book Value Analysis
Kimia Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 15.06 (High). View Kimia Biosciences 52-week for the annual high/low range and current price position.
- Stock appears overvalued with PB of 15.06, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 661.6% above historical average
- Trading at premium to sector average PB of -0.94
Kimia Biosciences P/B Ratio Historical Trend
KIMIABL annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Kimia Biosciences share price screener.
KIMIABL Historical P/B Ratio — Book Value Per Share & Year-End Price
Kimia Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.7 | ₹20.0 | ₹33.95 | ₹10 | Moderate |
| 2023 | 3.07 | ₹12.0 | ₹36.80 | ₹6 | High |
| 2022 | 1.43 | ₹30.0 | ₹43.00 | ₹15 | Moderate |
| 2021 | 1.71 | ₹36.0 | ₹61.60 | ₹18 | Moderate |
KIMIABL vs Healthcare Peers — P/B Ratio Comparison
Kimia Biosciences P/B 15.06 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |